This content is created by Smallcaps Authors. [Author : Filip Karinja]
The Therapeutic Goods Administration (TGA) has announced that from 1 July 2023, medicines containing psilocybin and MDMA can be prescribed by authorised psychiatrists. In an announcement made on Friday, the TGA says it will permit the prescribing of psilocybin for treatment-resistant depression (TRD) and MDMA for the treatment of post-traumatic stress disorder (PTSD). For these […]
The post Australia leads the way as TGA allows psilocybin and MDMA for treating depression and PTSD appeared first on Small Caps.
from Small Caps https://ift.tt/Lqs7TPo
إرسال تعليق